These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 3935620

  • 1. Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system.
    Yamaguchi T, Nakagawa M, Hidaka K, Yoshida T, Sasaki T, Akiyama S, Kuwano M.
    Jpn J Cancer Res; 1985 Oct; 76(10):1021-6. PubMed ID: 3935620
    [Abstract] [Full Text] [Related]

  • 2. Potentiation by vitamin A of the action of anticancer agents against murine tumors.
    Nakagawa M, Yamaguchi T, Ueda H, Shiraishi N, Komiyama S, Akiyama S, Ogata J, Kuwano M.
    Jpn J Cancer Res; 1985 Sep; 76(9):887-94. PubMed ID: 3932288
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
    Fujimoto S, Ogawa M, Hoshino A.
    Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
    Fujimoto S, Tashiro T, Ogawa M.
    Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
    [Abstract] [Full Text] [Related]

  • 5. [Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase].
    Dederer LIu, Sokolova IS, Bakhmedova AA, Miniker TD, Mel'nik SIa, Gorbacheva LB.
    Biokhimiia; 1995 Sep; 60(9):1521-9. PubMed ID: 8562657
    [Abstract] [Full Text] [Related]

  • 6. Distribution, excretion, and metabolism of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea (ACNU) in rats and mice after iv administration.
    Tanaka M, Nishigaki T, Nakajima E, Totsuka S, Nakamura K.
    Cancer Treat Rep; 1980 Sep; 64(4-5):575-80. PubMed ID: 6933003
    [Abstract] [Full Text] [Related]

  • 7. Distribution of radiolabeled 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitros ourea hydrochloride in rat brain tumor: intraarterial versus intravenous administration.
    Yamada K, Ushio Y, Hayakawa T, Arita N, Huang TY, Nagatani M, Yamada N, Mogami H.
    Cancer Res; 1987 Apr 15; 47(8):2123-8. PubMed ID: 3470138
    [Abstract] [Full Text] [Related]

  • 8. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
    Li LH, DeKoning TF, Wallace TL.
    Cancer Res; 1987 Nov 15; 47(22):5894-900. PubMed ID: 3664490
    [Abstract] [Full Text] [Related]

  • 9. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE, Green D, Schein PS.
    Cancer Res; 1986 May 15; 46(5):2340-3. PubMed ID: 2938728
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride in a variety of experimental tumors.
    Shimizu F, Arakawa M.
    Gan; 1978 Aug 15; 69(4):545-8. PubMed ID: 710804
    [Abstract] [Full Text] [Related]

  • 11. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
    Fujimoto S, Ogawa M, Sakurai Y.
    Cancer Res; 1982 Oct 15; 42(10):4079-85. PubMed ID: 6955008
    [No Abstract] [Full Text] [Related]

  • 12. Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose.
    Fujimoto S, Wang Y, Ogawa M.
    Cancer Chemother Pharmacol; 1984 Oct 15; 12(3):173-8. PubMed ID: 6584235
    [Abstract] [Full Text] [Related]

  • 13. Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats.
    Shimizu K, Ushio Y, Hayakawa T, Mogami H.
    Cancer Res; 1980 Apr 15; 40(4):1341-3. PubMed ID: 6153573
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Combined effect of CDDP with various types of antitumor drugs against P 388 leukemia].
    Uchida T, Nishikawa K, Shibasaki C, Okamoto K, Arakawa M, Ekimoto H, Takahashi K.
    Gan To Kagaku Ryoho; 1989 Jun 15; 16(6):2275-82. PubMed ID: 2735770
    [Abstract] [Full Text] [Related]

  • 16. A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
    Fujimoto S, Ogawa M.
    Cancer Chemother Pharmacol; 1982 Jun 15; 9(3):134-9. PubMed ID: 6218931
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
    Lin TS, Fischer PH, Marsh JC, Prusoff WH.
    Cancer Res; 1982 May 15; 42(5):1624-9. PubMed ID: 7066884
    [Abstract] [Full Text] [Related]

  • 18. Reversal of resistance to vincristine in P388 leukemia by various polycyclic clinical drugs, with a special emphasis on quinacrine.
    Inaba M, Maruyama E.
    Cancer Res; 1988 Apr 15; 48(8):2064-7. PubMed ID: 3349478
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor.
    Nakagawa M, Yamaguchi T, Fukawa H, Ogata J, Komiyama S, Akiyama S, Kuwano M.
    Jpn J Cancer Res; 1985 Apr 15; 76(4):315-20. PubMed ID: 2408954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.